European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors

NCT02813135 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

472

Enrollment

OTHER

Sponsor class

Conditions

Pediatric Cancer

Interventions

DRUG: Ribociclib
DRUG: Topotecan
DRUG: Temozolomide
DRUG: Everolimus
DRUG: Adavosertib
DRUG: Carboplatin
DRUG: Olaparib
DRUG: Irinotecan
DRUG: Vistusertib
DRUG: Nivolumab
DRUG: Cyclophosphamide
DRUG: Selumetinib
DRUG: Enasidenib
DRUG: Lirilumab
DRUG: Fadraciclib
DRUG: Cytarabine
DRUG: Dexamethasone
DRUG: Ceralasertib
DRUG: Futibatinib
DRUG: Capmatinib

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris

Collaborators

[object Object]
[object Object]
[object Object]